Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Nutcracker Therapeutics hired Rob Schott as chief medical officer. Previously, he worked at Sangamo Therapeutics, where he was senior vice president and head of development.
But all work and no play can make for a dull chief medical officer. So in his spare time, Schott likes to cycle. An avid cyclist for more than 25 years, he average about 6,000 to 7,000 miles a year on the road. And he treats the time spent as a biology experiment, meticulously tracking his heart rate, biologic parameters and power outputs. “I cycle with a certain amount of intensity and irregularity. I have a catalog on physiological data on myself… My life is working or working out.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect